Andrea Ghirardi is an international CEO, investor, and thought leader at the intersection of longevity, technology, and applied science. He leads Prolon (L-Nutra), a nutrition technology company focused on the “Food as Medicine” approach.

With over 15 years of experience across Europe and the United States, he has built and scaled science-driven businesses in complex, regulated environments. Under his leadership, L-Nutra’s European operations have expanded significantly through clinical research, digital platforms, and AI-enabled systems.

Beyond his executive role, Ghirardi serves as an active investor, chairman, and board member in healthcare and longevity ventures, and regularly speaks at international forums on AI, nutrition, and personalized medicine. He has been recognized among Forbes Italy’s Top 100 CEOs.